MAMAX
Price
$19.99
Change
+$0.05 (+0.25%)
Updated
Jun 2 closing price
Net Assets
6.32B
RLBFX
Price
$35.60
Change
+$0.14 (+0.39%)
Updated
Jun 2 closing price
Net Assets
241.02B
Interact to see
Advertisement

MAMAX vs RLBFX

Header iconMAMAX vs RLBFX Comparison
Open Charts MAMAX vs RLBFXBanner chart's image
MFS Moderate Allocation A
Price$19.99
Change+$0.05 (+0.25%)
VolumeN/A
Net Assets6.32B
American Funds American Balanced R5
Price$35.60
Change+$0.14 (+0.39%)
VolumeN/A
Net Assets241.02B
MAMAX vs RLBFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MAMAX vs. RLBFX commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAMAX is a Hold and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 241B vs. MAMAX (6.32B). MAMAX pays higher dividends than RLBFX: MAMAX (2.42) vs RLBFX (2.18). MAMAX was incepted earlier than RLBFX: MAMAX (23 years) vs RLBFX (23 years). MAMAX (0.90) is less costly to investors than RLBFX (0.29). RLBFX is a more actively managed with annual turnover of: 44.00 vs. MAMAX (4.00). RLBFX has a lower initial minimum investment than MAMAX: RLBFX (250) vs MAMAX (1000). RLBFX annual gain was more profitable for investors over the last year : 7.80 vs. MAMAX (3.81). RLBFX return over 5 years is better than : 37.05 vs. MAMAX (20.26).
MAMAXRLBFXMAMAX / RLBFX
Total Expense Ratio0.900.29310%
Annual Report Gross Expense Ratio0.900.29310%
Fund Existence23 years23 years-
Gain YTD4.0823.914104%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets6.32B241B3%
Annual Yield % from dividends2.422.18111%
Returns for 1 year3.817.8049%
Returns for 3 years10.8522.8747%
Returns for 5 years20.2637.0555%
Returns for 10 years39.7760.0966%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHSZX39.72N/A
N/A
PGIM Jennison Health Sciences Z
FDEIX25.38N/A
N/A
Fidelity Advisor Capital Development I
IVITX22.21N/A
N/A
VY® Invesco Growth and Income S2
GHAYX40.08N/A
N/A
VanEck Global Resources Fund Y
MSHNX13.98N/A
N/A
Morgan Stanley Inst Permanence A